Article Text
Therapeutics/Prevention
Systematic review
Evidence is weak to support hepatocellular carcinoma screening in chronic liver disease
Statistics from Altmetric.com
Footnotes
Competing interests None.
Provenance and peer review Commissioned; internally peer reviewed.